Orchestra BioMed Holdings, Inc. (OBIO): Cost of Revenue
$190.0K
Year ended 2025-12-31
$157.0K
Trailing 12 months to 2026-06-30
-3.4%
3-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $190.0K | -6.9% | 2026-03-12, From 2025-01-01 |
| 2024-12-31 | $204.0K | +9.7% | 2026-03-12, From 2024-01-01 |
| 2023-12-31 | $186.0K | -11.8% | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | $211.0K | n/a | 2024-03-27, From 2022-01-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | 2025-12-31 | $190.0K | -6.9% |
| Premier Air Charter Holdings Inc. (PREM) | 2025-12-31 | $28.49M | +55.2% |
| ClearPoint Neuro, Inc. (CLPT) | 2025-12-31 | $14.28M | +16.4% |
| Cytosorbents Corp (CTSO) | 2025-12-31 | $10.57M | -1.3% |
| Retractable Technologies Inc (RVP) | 2025-12-31 | $38.22M | +12.2% |
| Utah Medical Products Inc (UTMD) | 2025-12-31 | $16.52M | -1.4% |
| Interpace Biosciences, Inc. (IDXG) | 2025-12-31 | $14.60M | -14.1% |
| Sensus Healthcare, Inc. (SRTS) | 2025-12-31 | $15.62M | -10.1% |
| KORU Medical Systems, Inc. (KRMD) | 2025-12-31 | $15.52M | +26.1% |
Compare OBIO, PREM, CLPT, CTSO side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗